Key result
Nitric oxide fully reversed endothelin-1 constrictions in human conductance coronary arteries, but no tested endogenous vasodilator completely counteracted constrictions in resistance arteries.
In human coronary arteries, ET-1 is a more potent constrictor of resistance than conductance vessels, and endogenous vasodilators like NO cannot fully reverse this constriction in resistance vessels.
Answers are grounded in this paper and cite their sources.
ET-1 may predominate in coronary resistance vessel tone; leaves open its role in microvascular dysfunction pending in vivo confirmation.
The ability of four endogenous vasodilators, nitric oxide (NO; 0.01 - 30 microM), atrial (ANP), brain (BNP) and C-type (CNP) natriuretic peptide (0.1 - 300 nM), to reverse endothelin-1 (ET-1; 10 nM) constrictions in human resistance and conductance coronary arteries (CA) in vitro was investigated. ET-1 (0.1 - 300 nM) constricted resistance CA more potently than conductance CA (P<0.05; EC(50) values 2.98 nM (95% CI: 1.49 - 5.95 nM and 8.58 (4.72 - 15.6 nM) respectively)). The NO-donor diethylamine NONOate fully reversed the ET-1 constriction in conductance CA (E(MAX) 127+/-9.16%), however only partial reversal was observed in resistance CA (E(MAX) 78.8+/-8.13; P<0.05). The soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (100 microM) reduced the maximum response to diethylamine NONOate to 76.9+/-14.4% in conductance CA (P<0.05), but had no effect on resistance CA (E(MAX) 77.2+/-18.4%). There was no difference between responses to ANP in conductance and resistance CA (EC(50) values 4.25 nM (0.84 - 21.4 nM) and 18.4 nM (2.92 - 116 nM), E(MAX) 53.1+/-14.7% and 48.6+/-11.8% respectively). BNP was a more potent vasodilator of conductance than resistance CA. In conductance CA the mean EC(50) value was 2.4 nM (0.74 - 7.75 nM), E(MAX) 54.5+/-14.9%. Concentration-response curves to BNP were incomplete in resistance CA. Concentration-response curves to CNP were incomplete in both conductance and resistance CA. The greater potency of ET-1 in resistance vessels may exacerbate the effects of increased circulating levels of the peptide in disease. Only NO could fully reverse ET-1 mediated constrictions in conductance CA, and none of the dilators tested could completely counteract constrictions in resistance CA.
No takes yet. Share an insight, caveat, or question.
Wiley et al. (2001) studied In vitro human coronary arteries. Endogenous vasodilators (NO, ANP, BNP, CNP) was evaluated on Reversal of endothelin-1 constrictions. Nitric oxide fully reversed endothelin-1 constrictions in human conductance coronary arteries, but no tested endogenous vasodilator completely counteracted constrictions in resistance arteries.
Synapse has enriched 10 related papers. Consider them for comparative context: